DK2948129T3 - Terapeutiske forbindelser - Google Patents

Terapeutiske forbindelser

Info

Publication number
DK2948129T3
DK2948129T3 DK14742746.2T DK14742746T DK2948129T3 DK 2948129 T3 DK2948129 T3 DK 2948129T3 DK 14742746 T DK14742746 T DK 14742746T DK 2948129 T3 DK2948129 T3 DK 2948129T3
Authority
DK
Denmark
Prior art keywords
therapeutic compounds
compounds
eczema
wounds
psoriasis
Prior art date
Application number
DK14742746.2T
Other languages
Danish (da)
English (en)
Inventor
Weston J Hale
Thomas F Rau
Original Assignee
Wintermute Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wintermute Biomedical Inc filed Critical Wintermute Biomedical Inc
Application granted granted Critical
Publication of DK2948129T3 publication Critical patent/DK2948129T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DK14742746.2T 2013-01-25 2014-01-27 Terapeutiske forbindelser DK2948129T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361757058P 2013-01-25 2013-01-25
PCT/US2014/013120 WO2014117056A1 (en) 2013-01-25 2014-01-27 Therapeutic compounds

Publications (1)

Publication Number Publication Date
DK2948129T3 true DK2948129T3 (da) 2018-01-29

Family

ID=51228097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14742746.2T DK2948129T3 (da) 2013-01-25 2014-01-27 Terapeutiske forbindelser

Country Status (11)

Country Link
US (1) US10195242B2 (enExample)
EP (1) EP2948129B1 (enExample)
JP (1) JP6408489B2 (enExample)
AU (1) AU2014209162B2 (enExample)
CA (1) CA2894240C (enExample)
DK (1) DK2948129T3 (enExample)
ES (1) ES2659066T3 (enExample)
NO (1) NO2982810T3 (enExample)
PL (1) PL2948129T3 (enExample)
PT (1) PT2948129T (enExample)
WO (1) WO2014117056A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729575A (zh) * 2017-01-25 2017-05-31 深圳市艾梵诗生物技术有限公司 具有青少年抗菌消炎、祛痘淡印功效的中药组合物、美容产品及其制备方法
CA3052047A1 (en) * 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
MX2021003810A (es) * 2018-10-01 2021-07-06 Wintermute Biomedical Inc Composiciones terapeuticas.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150052A (en) 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US5766614A (en) * 1997-03-20 1998-06-16 Yong; Liu Burn treatment compositions containing herbal mix
JPH11269034A (ja) 1998-03-20 1999-10-05 Shiseido Co Ltd ニキビ改善用皮膚外用剤
JP2000281528A (ja) * 1999-03-31 2000-10-10 Ichimaru Pharcos Co Ltd 化粧料組成物
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
JP2002114670A (ja) 2000-10-02 2002-04-16 Noevir Co Ltd 抗菌性皮膚外用剤
US7288265B1 (en) * 2000-10-16 2007-10-30 Lectec Corporation Treating viral infection at smallpox vaccination site
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
EP1595936B1 (en) * 2003-01-27 2011-10-19 Vitamin C60 Bioresearch Corporation Composition for external use
CN100582089C (zh) 2003-11-21 2010-01-20 吉万奥丹股份有限公司 N-取代的对-薄荷烷甲酰胺
US20120328544A1 (en) 2003-12-22 2012-12-27 Nevada Naturals, Inc. Dermatological Treatment Methods And Formulations
JP4927718B2 (ja) 2004-06-18 2012-05-09 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト ブラックベリー抽出物
US7691418B2 (en) 2004-09-17 2010-04-06 Oystershell Nv Composition for inhibiting or preventing the formation of a biofilm
GB0423652D0 (en) 2004-10-25 2004-11-24 Univ Coventry Kit
BRPI0612448A2 (pt) * 2005-05-09 2010-11-23 Foamix Ltd composição espumosa de sacarìdeo
CN1969984B (zh) 2006-12-07 2010-12-29 刘爱芹 一种治疗皮肤粉刺和过敏的外用药
TWI428140B (zh) * 2007-03-09 2014-03-01 Otsuka Pharma Co Ltd A freeze-dried preparation containing influenza vaccine and a method for producing the same
US8623335B2 (en) 2007-09-10 2014-01-07 Tauna Ann Waddington Scar and rosacea and other skin care treatment composition and method
CN101991726A (zh) * 2009-08-25 2011-03-30 肖华 一种治疗巨细胞病毒的药物组合物及其制备方法
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
CN102178842B (zh) 2011-04-27 2013-10-16 李梅华 一种治疗结核病的药物组合物及应用
CA2957790A1 (en) 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof

Also Published As

Publication number Publication date
PT2948129T (pt) 2018-02-12
JP6408489B2 (ja) 2018-10-17
EP2948129B1 (en) 2017-11-22
AU2014209162A1 (en) 2015-06-04
US20150366925A1 (en) 2015-12-24
NO2982810T3 (enExample) 2018-08-04
AU2014209162B2 (en) 2016-03-24
PL2948129T3 (pl) 2018-05-30
EP2948129A4 (en) 2016-08-31
WO2014117056A1 (en) 2014-07-31
EP2948129A1 (en) 2015-12-02
ES2659066T3 (es) 2018-03-13
JP2016510332A (ja) 2016-04-07
CA2894240A1 (en) 2014-07-31
CA2894240C (en) 2019-01-08
US10195242B2 (en) 2019-02-05

Similar Documents

Publication Publication Date Title
PH12019502269A1 (en) Quinazoline derivatives for the treatment of viral infections and further diseases
EA201590343A1 (ru) Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний
CA2925624C (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112015016315A2 (pt) fluoro-[1,3]oxazinas como inibidores de bace1
EA201300558A1 (ru) Соединения и способы для купирования боли
EA201690687A1 (ru) Ингибиторы репликации вируса иммунодефицита
EA201291336A1 (ru) Замещенные 5-фтор-1н-пиразолопиридины и их применение
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201790660A1 (ru) Ингибитор киназ
HUE039864T2 (hu) Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére
WO2015054619A8 (en) Use of a pcsk9 inhibitor to treat hyperlipidemia
WO2013052943A3 (en) Small molecule inhibitors of mcl-1 and uses thereof
WO2016100347A3 (en) Small molecule inhibitors of egfr and pi3k
EA201491854A1 (ru) Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
BR112015019412A2 (pt) inibidores de bace1
HK1217092A1 (zh) 治疗性化合物及其用途
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
MD4629B1 (ro) Metode de tratament a fibrozei şi cancerului
BR112015028890A2 (pt) derivados de piridona para o tratamento de infecções virais e outras doenças
BR112014015578A2 (pt) composições farmacêuticas tópicas compreendendo bexaroteno e um corticosteróide
EA201500232A1 (ru) Три(гетеро)арилпиразолы и их применение
BR112016007430A2 (pt) 5-aril-1-imino-1-oxo-[1,2,4]tiadiazinas
JP2016510332A5 (enExample)